Physician profile
Ali Sharp
NPI 1346826757
$1,110.13
in general payments reported to CMS, 2019-2025
10 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $184 · 2023: $564 · 2024: $161 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $243.78 | 2024-2025 | Novosorb Btm |
| Inari Medical, INC. | $187.80 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $162.31 | 2023 | Spy-Phi System |
| Boston Scientific Corporation | $162.11 | 2022-2025 | Accolade Sr |
| Heron Therapeutics, INC. | $121.01 | 2023 | Aponvie |
| Abbvie INC. | $86.14 | 2025 | |
| Conmed Corporation | $66.67 | 2023 | Airseal |
| Astrazeneca Pharmaceuticals Lp | $45.92 | 2022-2023 | Andexxa |
| Aimmune Therapeutics, INC. | $18.49 | 2025 | Zenpep |
| Takeda Pharmaceuticals U.S.A., INC. | $15.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Sharp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.